Naomi Aronson, PhD Executive Director of Clinical Evaluation Innovation & Policy Office of Clinical Affairs Blue Cross, Blue Shield Association
Cell & Gene Therapy Europe will bring together 250 of the continent's leading cell and gene therapy experts! With over 70 speakers on this packed, cutting edge conference agenda you can't afford to miss this exciting new event. - Hear from the regulators who have designed optimal pathways streamlining your route to market including the Big 5: France, Germany, Italy, Spain & the UK - Meet the investors: network with private and public sector representatives who are investing in ATMPs now! - Discover the pricing & reimbursement stories behind Holoclar, Glybera, and ChondroSelect from the CEOs of Holostem, uniQure & Tigenix - Centralised and decentralised manufacturing models: A practical lesson - Innovation stories: CARTs, genome editing platforms, eSCs and iPS cell technologies - How to guide: Differences between European, US and Japanese regulatory guidelines - Network with Europe's elite with 80% of attendees from Europe, and 77% of attendees Director and above - Sun, cells and Sangria! Enjoy business networking in one of the most vibrant and beautiful cities in Europe View the unbeatable speaker list and cutting edge conference agenda at www.cgteurope.com now!
- THE Big Data meeting for drug development budget holders - Transforming theory into action, value and competitive advantage - Capitalizing on the promise of real world evidence throughout the clinical development process In the wake of the highly successful launch of the Big Data Leaders Forum in October 2014, Phacilitate received extremely positive feedback that a specific focus on the application of Big Data-derived insights in translational and clinical R&D was a strong feature and differentiator of the event. In 2015, the event is renamed ‘Big Data in Clinical Development’ - a signal of intent to provide even more real-world examples of strategies improving decision-making during this most risky and expensive, but also potentially rewarding stage of the overall drug discovery, development and commercialization process. Attendees will receive unique insights into where the major industry players are placing their bets to ensure Big Data in drug development provides a critical source of competitive advantage for years to come. They will also discover the right questions to ask of Big Data throughout the product lifecycle in order to build a more comprehensive body of real world evidence, and a better prediction of value. Meet the senior leaders representing all of the functions that directly influence - and ultimately make- the decision of how individual pharma, CRO and biotech companies will harness the potential of Big Data to improve their clinical development strategies and results.
Brand new for 2015, Phacilitate is delighted to present a meeting specifically aimed at the pharma, biotech and healthcare sector leaders currently implementing strategies to harness the potential of eHealth solutions, including mHealth devices. The meeting will be collocated with Big Data in Clinical Development - all attendees will enjoy equal access to attendees from both conferences, and all networking breaks, functions and the online 121 Partnering Tool will be shared. Phacilitate looks forward to expanding the event’s audience to include the payers, KOLs, pharma/biotech leaders, eHealth and mHealth technology/service providers, IT infrastructure companies and other key stakeholders who between them will dictate the shape of the healthcare delivery model for years to come. Agenda research is now underway for the inaugural Phacilitate eHealth event - contact us today to register your interest and have your say on preferred topics and speakers!
World leading. - Longest established – 12th Annual in 2016 - Largest – 150+ speakers, 600+ attendees, 60+ exhibitors - More decision-makers – 80% Director level+ For Phacilitate, Washington 2016 is all about building on this position of strength to deliver the undisputed leader in novel biologics industry events worldwide. • Significantly larger expo & 121 Partnering Area offers more Private Meeting Booths and exciting new features: o Innovation Accelerator Theatre - brings the agenda to the expo floor o Regional Pavillions - helping ensure Washington 2016 is number 1 globally • Expanded agenda – more in-depth coverage of the key manufacturing, logistical, R&D and regulatory challenges and solutions • More interactive formats – ‘Interactive Hours’ every day, Tech Room Demonstrations, Roundtables, ‘Drop-in Clinics’ and more. • Stars of the Future – new feature welcomes the next generation of innovation and talent to join in the debate shaping the future of the Cell & Gene Therapy and Immunotherapy industries. Guarantee your place, optimize your involvement, maximize your ROI. Contact Phacilitate today!
Mark Trusheim Visiting Scientist MIT Sloan School of Management
Perry Karsen Chief Executive Officer Celgene Cellular Therapeutics
David Hall Chief Executive Officer Replicel
James L. Gulley, MD, PhD, FACP Chief, Genitourinary Malignancies Branch, Director, Medical Oncology Service, Center for Cancer Research National Cancer Institute